ArticlePLoS neglected tropical diseases2026
Completion of rabies post-exposure prophylaxis in Ouagadougou, Burkina Faso, 2021-2023: A cross-sectional analysis of routine data.
Article in PLoS neglected tropical diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRabies remains a major public health concern in low- and middle-income countries, where completion of post-exposure prophylaxis (PEP) is essential to prevent fatal outcomes. Large-scale programmatic evidence from francophone West Africa remains limited. MATERIAL AND
methodsWe conducted a cross-sectional analytical study using routine data from the Ouagadougou Anti-Rabies Center between 2021 and 2023. Among 8,220 patients receiving rabies prophylaxis, 8,063 (98.1%) received PEP and were included in the analytical component. Completion was defined according to clinical practice, including full vaccination or medically advised discontinuation following risk assessment. Multivariable logistic regression was used to identify factors associated with PEP completion. Dose-specific default patterns were also analyzed.
resultsOverall, 60.2% of patients completed PEP, with a decline from 77% in 2021 to 37% in 2023, coinciding with a documented vaccine stockout. Male sex (aOR=0.89; 95% CI: 0.81-0.98) and age 15-25 years (aOR=0.82; 95% CI: 0.69-0.97) were associated with lower completion. Urban residence was associated with higher completion in the main model (aOR=1.22), although this effect varied significantly by year (interaction p=0.001).
conclusionPEP completion in Ouagadougou is primarily driven by socio-demographic and structural factors rather than exposure severity. Early dropout represents a critical intervention point. Strengthening access, decentralizing services, and improving follow-up are essential to enhance completion in endemic settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.